Kraaijenhof, J. M. (2025). Inflammation and lipids in atherosclerosis: From disease mechanisms to therapeutic targeting. [Thesis, fully internal, Universiteit van Amsterdam].
Oostveen, R. F. (2025). Innovative imaging for the assessment of cardiovascular risk modulation. [Thesis, fully internal, Universiteit van Amsterdam].
Ibrahim, S. (2024). Familial hypercholesterolemia: Novel strategies to improve detection and treatment. [Thesis, fully internal, Universiteit van Amsterdam].
Cupido, A. J. (2023). Human genetics and big data to guide cardiovascular drug development. [Thesis, fully internal, Universiteit van Amsterdam].
Tromp, T. R. T. M. (2023). Understanding familial hypercholesterolemia: From extremes to unexplained. [Thesis, fully internal, Universiteit van Amsterdam].
Reeskamp, L. F. (2021). Familial hypercholesterolemia: Closing the loop between molecular genetics and personalized medicine. [Thesis, fully internal, Universiteit van Amsterdam].
Hartgers, M. L. (2020). Familial hypercholesterolemia: From genetic and clinical diversity towards tailored therapy. [Thesis, fully internal, Universiteit van Amsterdam].
Bruikman, C. S. (2020). Familial atherosclerosis and neuroimmune guidance cues: From in vitro assessments to clinical events. [Thesis, fully internal, Universiteit van Amsterdam].
Verbeek, R. (2019). Lp(a) and PCSK9: From concept to clinical practice. [Thesis, fully internal, Universiteit van Amsterdam].
Stoekenbroek, R. M. (2019). High risk cardiovascular disease: From insight to therapy. [Thesis, fully internal, Universiteit van Amsterdam].
